TDAmeritrade - New Portfolio

Reynaldo

TDAmeritrade
Individual Investor
Ranked #262,161 out of 766,001 TipRanks' Investors
Success Rate
49%
833 out of 1692
profitable transactions
Average Return
16.70%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 6.15%
6-Month Return▲ 7.06%
12-Month Return▲ 88.96%
YTD Return▲ 58.90%
Total Return▲ 127.32%

Best Trade

Opened at
Closed at-
Gain▲ 2916.09%

Bio

Mixed back of stocks with good analyst ratings purchased during oversold dips (RSI 30-40), and showing stock drop of 30% or more in prior 6 months.

Performance

25.72%0-25.72%
▼ 12.40%
▼ 4.03%
▼ 5.36%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 6.95%
May 2024
▼ 2.25%
▲ 3.53%
▼ 6.02%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 7.82%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 3.61%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 2.59%
Sep 2024
▲ 6.02%
▼ 0.89%
▲ 1.76%
Oct 2024
▲ 5.59%
▲ 5.20%
▲ 2.64%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 5.36%
▲ 11.46%▲ 5.06%▲ 6.95%
▼ 2.25%▲ 3.53%▼ 6.02%
▲ 25.72%▲ 1.21%▲ 7.82%
▼ 4.22%▲ 2.34%▼ 3.61%
▲ 7.82%▲ 2.10%▲ 2.59%
▲ 6.02%▼ 0.89%▲ 1.76%
▲ 5.59%▲ 5.20%▲ 2.64%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Iteris
▲ 56.99%
3
Close
Oct 31, 2024
Guardion Health Sciences
▼ 94.01%
6
Close
Oct 30, 2024
Petiq
▼ 2.91%
2
Close
Oct 24, 2024
Phasebio Pharmaceuticals
▼ 99.30%
2
Close
Oct 01, 2024
Eiger Biopharmaceuticals
▼ 97.05%
3
Close
Oct 01, 2024
Vapotherm
▼ 99.01%
2
Close
Sep 20, 2024
G1 Therapeutics
▼ 54.85%
8
Close
Sep 17, 2024
Curo Group Holdings
▼ 99.42%
2
Close
Jul 19, 2024
Argonaut Gold
▼ 79.14%
2
Close
Jul 16, 2024
Alamos Gold
0.11%
▲ 9.08%
1
Open
Jul 16, 2024
Atreca
▼ 99.37%
5
Close
Jun 14, 2024
NeuBase Therapeutics
▼ 99.76%
5
Close
May 10, 2024
Amyris
▼ 99.50%
4
Close
May 07, 2024
Societal CDMO
▼ 58.70%
8
Close
Apr 09, 2024
Calithera Bio
▼ 99.97%
2
Close
Apr 05, 2024
Aravive
▼ 99.27%
4
Close
Jan 26, 2024
Orchard Therapeutics
▼ 75.00%
8
Close
Jan 24, 2024
Bluegreen Vacations Holding
▲ 367.85%
8
Close
Jan 16, 2024
Axcella Health
▼ 99.66%
4
Close
Dec 29, 2023
Rubius Therapeutics
▼ 98.86%
3
Close
Dec 29, 2023